throbber
GENERAL LEAVE
`Mr. BOEHNER. Mr. Speaker, I ask
`unanimous consent that all Members
`may have 5 legislative days within
`which to revise and extend their re-
`marks and include extraneous material
`on the subject of the concurrent resolu-
`tion just considered.
`The SPEAKER pro tempore. Is there
`objection to the request of the gen-
`tleman from Ohio?
`There was no objection.
`
`H55
`January 31, 2000
`CONGRESSIONAL RECORD — HOUSE
`Mr. HOYER. Mr. Speaker, I yield
`thing that was rather routine in ses-
`number of cases. It is difficult to isolate the im-
`pact of such drug’s ingestion since it is so typi-
`back the balance of my time.
`sions past, but over a period of 3 or 4
`cally taken with an ever-changing array of
`Mr. BOEHNER. Mr. Speaker, I want
`sessions it did not occur. Several years
`other drugs and especially alcohol which
`to thank my colleague, the gentleman
`ago when this was done the Members
`potentiates its impact.
`from Maryland (Mr. HOYER), for his
`were very supportive of the effort, and
`(3) GHB takes the same path as alcohol, proc-
`support, and I yield back the balance of
`the Committee on House Administra-
`esses via alcohol dehydrogenase, and its symp-
`my time.
`tion voted for it. The Members thereof
`toms at high levels of intake and as impact
`The SPEAKER pro tempore. The
`have suggested that the House take an-
`builds are comparable to alcohol ingestion/in-
`question is on the motion offered by
`other photograph in this session.
`toxication. Thus, aggression and violence can be
`expected in some individuals who use such drug.
`Mr. Speaker, I reserve the balance of
`the
`gentleman
`from Ohio
`(Mr.
`(4) If taken for human consumption, common
`my time.
`BOEHNER) that the House suspend the
`industrial chemicals such as gamma butyro-
`Mr. HOYER. Mr. Speaker, I yield my-
`rules and agree to the concurrent reso-
`lactone and 1.4-butanediol are swiftly converted
`self such time as I may consume.
`lution, H. Con. Res. 244.
`by the body into GHB. Illicit use of these and
`Mr. Speaker, my staff behind me has
`The question was taken.
`other GHB analogues and precursor chemicals is
`suggested that Members should not for-
`Mr. BOEHNER. Mr. Speaker, on that
`a significant and growing law enforcement
`get to smile. I think it is appropriate
`I demand the yeas and nays.
`problem.
`(5) A human pharmaceutical formulation of
`that we take a picture of the House of
`The yeas and nays were ordered.
`gamma hydroxybutyric acid is being developed
`Representatives and its Members on an
`The SPEAKER pro tempore. Pursu-
`as a treatment for cataplexy, a serious and de-
`annual basis, or at least once during
`ant to clause 8 of rule XX and the
`bilitating disease. Cataplexy, which causes sud-
`every Congress. I think this is not only
`Chair’s prior announcement, further
`den and total loss of muscle control, affects
`a substantial memento for those who
`proceedings on this motion will be
`about 65 percent of the estimated 180,000 Ameri-
`have the great honor and privilege of
`postponed.
`cans with narcolepsy, a sleep disorder. People
`serving here, but as well, an historical
`with cataplexy often are unable to work, drive
`record of those who are here, and of
`a car, hold their children or live a normal life.
`(6) Abuse of illicit GHB is an imminent hazard
`course I rise in strong support of the
`to public safety that requires immediate regu-
`resolution.
`latory action under the Controlled Substances
`Mr. Speaker, I yield back the balance
`Act (21 U.S.C. 801 et seq.).
`of my time.
`Mr. BOEHNER. Mr. Speaker, I yield
`SEC. 3. EMERGENCY SCHEDULING OF GAMMA HY-
`back the balance of my time.
`DROXYBUTYRIC ACID AND LISTING
`OF GAMMA BUTYROLACTONE AS
`The SPEAKER pro tempore (Mr.
`LIST I CHEMICAL.
`(a) EMERGENCY SCHEDULING OF GHB.—
`PETRI). The question is on the motion
`(1) IN GENERAL.—The Congress finds that the
`offered by the gentleman from Ohio
`abuse of illicit gamma hydroxybutyric acid is an
`(Mr. BOEHNER) that is House suspend
`imminent hazard to the public safety. Accord-
`the rules and agree to the resolution,
`ingly, the Attorney General, notwithstanding
`H. Res. 407.
`sections 201(a), 201(b), 201(c), and 202 of the
`The question was taken; and (two-
`Controlled Substances Act, shall issue, not later
`thirds having voted in favor thereof),
`than 60 days after the date of the enactment of
`this Act, a final order that schedules such drug
`the rules were suspended and the reso-
`(together with its salts, isomers, and salts of iso-
`lution was agreed to.
`mers) in the same schedule under section 202(c)
`A motion to reconsider was laid on
`of the Controlled Substances Act as would apply
`the table.
`to a scheduling of a substance by the Attorney
`General under section 201(h)(1) of such Act (re-
`lating to imminent hazards to the public safety),
`AND
`FARIAS
`J.
`HILLORY
`except as follows:
`SAMANTHA REID DATE-RAPE
`(A) For purposes of any requirements that re-
`DRUG PROHIBITION ACT OF 1999
`late to the physical security of registered manu-
`facturers and registered distributors, the final
`Mr. UPTON. Mr. Speaker, I move to
`order shall treat such drug, when the drug is
`suspend the rules and concur in the
`manufactured, distributed, or possessed in ac-
`Senate amendments to the bill (H.R.
`cordance with an exemption under section 505(i)
`2130) to amend the Controlled Sub-
`of the Federal Food, Drug, and Cosmetic Act
`stances Act to add gamma hydroxy-
`(whether the exemption involved is authorized
`butyric acid and ketamine to the
`before, on, or after the date of the enactment of
`schedules of controlled substances, to
`this Act), as being in the same schedule as that
`provide for a national awareness cam-
`recommended by the Secretary of Health and
`Human Services for the drug when the drug is
`paign, and for other purposes.
`the subject of an authorized investigational new
`The Clerk read as follows:
`drug application (relating to such section
`Senate amendments:
`505(i)). The recommendation referred to in the
`Strike out all after the enacting clause and
`preceding sentence is contained in the first
`insert:
`paragraph of the letter transmitted on May 19,
`1999, by such Secretary (acting through the As-
`SECTION 1. SHORT TITLE.
`This Act may be cited as the ‘‘Hillory J.
`sistant Secretary for Health) to the Attorney
`Farias and Samantha Reid Date-Rape Drug
`General (acting through the Deputy Adminis-
`Prohibition Act of 1999’’.
`trator of the Drug Enforcement Administration),
`which letter was in response to the letter trans-
`SEC. 2. FINDINGS.
`Congress finds as follows:
`mitted by the Attorney General (acting through
`(1) Gamma hydroxybutyric acid (also called G,
`such Deputy Administrator) on September 16,
`Liquid X, Liquid Ecstasy, Grievous Bodily
`1997. In publishing the final order in the Fed-
`Harm, Georgia Home Boy, Scoop) has become a
`eral Register, the Attorney General shall publish
`significant and growing problem in law enforce-
`a copy of the letter that was transmitted by the
`ment. At least 20 States have scheduled such
`Secretary of Health and Human Services.
`(B) In the case of gamma hydroxybutyric acid
`drug in their drug laws and law enforcement of-
`that is contained in a drug product for which
`ficials have been experiencing an increased pres-
`an application is approved under section 505 of
`ence of the drug in driving under the influence,
`the Federal Food, Drug, and Cosmetic Act
`sexual assault, and overdose cases especially at
`(whether the application involved is approved
`night clubs and parties.
`(2) A behavioral depressant and a hypnotic,
`before, on, or after the date of the enactment of
`gamma hydroxybutyric acid (‘‘GHB’’) is being
`this Act), the final order shall schedule such
`used in conjunction with alcohol and other
`drug in the same schedule as that recommended
`drugs with detrimental effects in an increasing
`by the Secretary of Health and Human Services
`
`PERMITTING OFFICIAL PHOTO-
`GRAPHS OF HOUSE WHILE IN
`SESSION
`Mr. BOEHNER. Mr. Speaker, I move
`to suspend the rules and agree to the
`resolution (H. Res. 407) permitting offi-
`cial photographs of the House of Rep-
`resentatives to be taken while the
`House is in actual session.
`The Clerk read as follows:
`H. RES. 407
`Resolved, That at a time designated by the
`Speaker of the House of Representatives, of-
`ficial photographs of the House may be
`taken while the House is in actual session.
`Payment for the costs associated with tak-
`ing, preparing, and distributing such photo-
`graphs may be made from the applicable ac-
`counts of the House of Representatives.
`The SPEAKER pro tempore. Pursu-
`ant to the rule, the gentleman from
`Ohio (Mr. BOEHNER) and the gentleman
`from Maryland (Mr. HOYER) each will
`control 20 minutes.
`The Chair recognizes the gentleman
`from Ohio (Mr. BOEHNER).
`1415
`Mr. BOEHNER. Mr. Speaker, I yield
`myself such time as I may consume.
`Mr. Speaker, this resolution is very
`straightforward and simply authorizes
`the use of the Chamber for a photo
`while we are in session. The Speaker
`would set the date for such photo and
`payment as authorized from the appli-
`cable accounts of the House.
`As Members know, in the last session
`of Congress there was a photo taken of
`all of the Members of the House, some-
`
`VerDate 27-JAN-2000 02:05 Feb 01, 2000 Jkt 079060 PO 00000 Frm 00005 Fmt 4634 Sfmt 6333 E:\CR\FM\K31JA7.012 pfrm02 PsN: H31PT1
`
`JAZZ EXHIBIT 2012
`Par Pharm., Inc. et al. (Petitioners) v. Jazz Pharms., Inc. (Patent Owner)
`Case CBM2014-00151
`
`Page 1 of 8
`
`

`

`H56
`January 31, 2000
`CONGRESSIONAL RECORD — HOUSE
`for authorized formulations of the drug. The
`(2) make such protocols and training materials
`‘‘(3) That every person who is registered as a
`recommendation referred to in the preceding
`available to Federal, State, and local personnel
`manufacturer of bulk or dosage form shall re-
`sentence is contained in the last sentence of the
`responsible for such investigations.
`port all manufacturing transactions both inven-
`(b) GRANT.—
`fourth paragraph of the letter referred to in sub-
`tory increases, including purchases, transfers,
`(1) IN GENERAL.—The Attorney General shall
`paragraph (A) with respect to May 19, 1999.
`and returns, and reductions from inventory, in-
`(2) FAILURE TO ISSUE ORDER.—If the final
`make a grant, in such amount and to such pub-
`cluding sales, transfers, theft, destruction, and
`order is not issued within the period specified in
`lic or private person or entity as the Attorney
`seizure, and shall provide data on material
`paragraph (1), gamma hydroxybutyric acid (to-
`General considers appropriate, for the develop-
`manufactured, manufactured from other mate-
`gether with its salts, isomers, and salts of iso-
`ment of forensic field tests to assist law enforce-
`rial, use in manufacturing other material, and
`mers) is deemed to be scheduled under section
`ment officials in detecting the presence of
`use in manufacturing dosage forms.
`202(c) of the Controlled Substances Act in ac-
`gamma hydroxybutyric acid and related sub-
`‘‘(4) That all reports under this section must
`cordance with the policies described in para-
`stances.
`include the registered person’s registration num-
`(2) AUTHORIZATION OF APPROPRIATIONS.—
`graph (1), as if the Attorney General had issued
`ber as well as the registration numbers, names,
`There are authorized to be appropriated such
`a final order in accordance with such para-
`and other identifying information of vendors,
`sums as may be necessary to carry out this sub-
`graph.
`suppliers, and customers, sufficient to allow the
`(b) ADDITIONAL PENALTIES RELATING TO
`section.
`Attorney General to track the receipt and dis-
`GHB.—
`(c) REPORT.—Not later than 180 days after the
`tribution of the drug.
`(1) CONTROLLED SUBSTANCES ACT.—
`date of the enactment of this Act, the Attorney
`‘‘(5) That each dispensing practitioner shall
`(A) IN GENERAL.—Section 401(b)(1)(C) of the
`General shall submit to the Committees on the
`maintain for each prescription the name of the
`Controlled
`Substances Act
`(21 U.S.C.
`Judiciary of the Senate and House of Represent-
`prescribing practitioner, the prescribing practi-
`841(b)(1)(C)) is amended in the first sentence by
`atives a report on current mechanisms for co-
`tioner’s Federal and State registration numbers,
`inserting after ‘‘schedule I or II,’’ the following:
`ordinating Federal, State, and local investiga-
`with the expiration dates of these registrations,
`‘‘gamma hydroxybutyric acid (including when
`tions into and prosecutions related to possible
`verification that the prescribing practitioner
`scheduled as an approved drug product for pur-
`violations of the Controlled Substances Act or
`possesses the appropriate registration to pre-
`poses of section 3(a)(1)(B) of the Hillory J.
`other Federal or State laws that result in or
`scribe this controlled substance, the patient’s
`Farias and Samantha Reid Date-Rape Drug
`contribute to rape, other crimes of violence, or
`name and address, the name of the patient’s in-
`Prohibition Act of 1999),’’.
`other crimes involving the abuse of gamma hy-
`surance provider and documentation by a med-
`AMENDMENT.—Section
`(B)
`CONFORMING
`droxybutyric acid, other controlled substances,
`ical practitioner licensed and registered to pre-
`401(b)(1)(D) of the Controlled Substances Act (21
`or so-called ‘‘designer drugs’’. The report shall
`scribe the drug of the patient’s medical need for
`U.S.C. 841(b)(1)(D)) is amended by striking ‘‘, or
`also include recommendations for the improve-
`the drug. Such information shall be available
`30’’ and inserting ‘‘(other than gamma hydroxy-
`ment of such mechanisms.
`for inspection and copying by the Attorney Gen-
`butyric acid), or 30’’.
`eral.
`(2) CONTROLLED SUBSTANCES IMPORT AND EX-
`SEC. 7. ANNUAL REPORT REGARDING DATE-RAPE
`‘‘(6) That section 310(b)(3) (relating to mail
`PORT ACT.—
`DRUGS; NATIONAL AWARENESS CAM-
`order reporting) applies with respect to gamma
`(A) IN GENERAL.—Section 1010(b)(3) of the
`PAIGN.
`(a) ANNUAL REPORT.—The Secretary of Health
`hydroxybutyric acid to the same extent and in
`Controlled Substances Import and Export Act
`and Human Services (in this section referred to
`the same manner as such section applies with
`(21 U.S.C. 960(b)(3)) is amended in the first sen-
`as the ‘‘Secretary’’) shall periodically submit to
`respect to the chemicals and drug products spec-
`tence by inserting after ‘‘I or II,’’ the following:
`Congress reports each of which provides an esti-
`ified in subparagraph (A)(i) of such section.’’.
`‘‘gamma hydroxybutyric acid (including when
`mate of the number of incidents of the abuse of
`scheduled as an approved drug product for pur-
`date-rape drugs (as defined in subsection (c))
`SEC. 5. CONTROLLED SUBSTANCES ANALOGUES.
`(a) RULE OF CONSTRUCTION REGARDING CON-
`poses of section 3(a)(1)(B) of the Hillory J.
`that occurred during the most recent one-year
`SUBSTANCE
`ANALOGUES.—Section
`Farias and Samantha Reid Date-Rape Drug
`TROLLED
`period for which data are available. The first
`102(32) of the Controlled Substances Act (21
`Prohibition Act of 1999),’’.
`such report shall be submitted not later than
`U.S.C. 802(32)) is amended—
`AMENDMENT.—Section
`(B)
`CONFORMING
`January 15, 2000, and subsequent reports shall
`(1) in subparagraph (A), by striking ‘‘sub-
`1010(b)(4) of the Controlled Substances Import
`be submitted annually thereafter.
`paragraph (B)’’ and inserting ‘‘subparagraph
`and Export Act (21 U.S.C. 960(b)(4)) is amended
`(b) NATIONAL AWARENESS CAMPAIGN.—
`(C)’’;
`by striking ‘‘flunitrazepam)’’ and inserting the
`(1) DEVELOPMENT OF PLAN; RECOMMENDATIONS
`(2) by redesignating subparagraph (B) as sub-
`following: ‘‘flunitrazepam and except a viola-
`OF ADVISORY COMMITTEE.—
`paragraph (C); and
`tion involving gamma hydroxybutyric acid)’’.
`(A) IN GENERAL.—The Secretary, in consulta-
`(3) by inserting after subparagraph (A) the
`(c) GAMMA BUTYROLACTONE AS ADDITIONAL
`tion with the Attorney General, shall develop a
`following new subparagraph (B):
`LIST I CHEMICAL.—Section 102(34) of the Con-
`plan for carrying out a national campaign to
`‘‘(B) The designation of gamma butyrolactone
`trolled Substances Act (21 U.S.C. 802(34)) is
`educate individuals described in subparagraph
`or any other chemical as a listed chemical pur-
`amended—
`(B) on the following:
`(1) by redesignating subparagraph (X) as sub-
`suant to paragraph (34) or (35) does not pre-
`(i) The dangers of date-rape drugs.
`paragraph (Y); and
`clude a finding pursuant to subparagraph (A) of
`(ii) The applicability of the Controlled Sub-
`(2) by inserting after subparagraph (W) the
`this paragraph that the chemical is a controlled
`stances Act to such drugs, including penalties
`following subparagraph:
`substance analogue.’’.
`under such Act.
`‘‘(X) Gamma butyrolactone.’’.
`(b) DISTRIBUTION WITH INTENT TO COMMIT
`(iii) Recognizing the symptoms that indicate
`CRIME OF VIOLENCE.—Section 401(b)(7)(A) of the
`an individual may be a victim of such drugs, in-
`SEC. 4. AUTHORITY FOR ADDITIONAL REPORTING
`Controlled
`Substances Act
`(21 U.S.C.
`cluding symptoms with respect to sexual assault.
`REQUIREMENTS FOR GAMMA HY-
`841(b)(7)(A)) is amended by inserting ‘‘or con-
`DROXYBUTYRIC
`PRODUCTS
`IN
`(iv) Appropriately responding when an indi-
`trolled substance analogue’’ after ‘‘distributing
`SCHEDULE III.
`vidual has such symptoms.
`Section 307 of the Controlled Substances Act
`a controlled substance’’.
`(B) INTENDED POPULATION.—The individuals
`(21 U.S.C. 827) is amended by adding at the end
`referred to in subparagraph (A) are young
`the following:
`SEC. 6. DEVELOPMENT OF MODEL PROTOCOLS,
`adults, youths, law enforcement personnel, edu-
`‘‘(h) In the case of a drug product containing
`TRAINING MATERIALS, FORENSIC
`cators, school nurses, counselors of rape victims,
`gamma hydroxybutyric acid for which an appli-
`FIELD TESTS, AND COORDINATION
`and emergency room personnel in hospitals.
`cation has been approved under section 505 of
`MECHANISM FOR INVESTIGATIONS
`(C) ADVISORY COMMITTEE.—Not later than 180
`AND PROSECUTIONS RELATING TO
`the Federal Food, Drug, and Cosmetic Act, the
`GAMMA HYDROXYBUTYRIC ACID,
`days after the date of the enactment of this Act,
`Attorney General may, in addition to any other
`OTHER CONTROLLED SUBSTANCES,
`the Secretary shall establish an advisory com-
`requirements that apply under this section with
`AND DESIGNER DRUGS.
`(a) IN GENERAL.—The Attorney General, in
`mittee to make recommendations to the Sec-
`respect to such a drug product, establish any of
`consultation with the Administrator of the Drug
`retary regarding the plan under subparagraph
`the following as reporting requirements:
`Enforcement Administration and the Director of
`(A). The committee shall be composed of individ-
`‘‘(1) That every person who is registered as a
`the Federal Bureau of Investigation, shall—
`uals who collectively possess expertise on the ef-
`manufacturer of bulk or dosage form, as a pack-
`(1) develop—
`fects of date-rape drugs and on detecting and
`ager, repackager, labeler, relabeler, or dis-
`(A) model protocols for the collection of toxi-
`controlling the drugs.
`tributor shall report acquisition and distribution
`cology specimens and the taking of victim state-
`(2) IMPLEMENTATION OF PLAN.—Not later than
`transactions quarterly, not later than the 15th
`ments in connection with investigations into
`180 days after the date on which the advisory
`day of the month succeeding the quarter for
`and prosecutions related to possible violations of
`committee under paragraph (1) is established,
`which the report is submitted, and annually re-
`the Controlled Substances Act or other Federal
`the Secretary, in consultation with the Attorney
`port end-of-year inventories.
`‘‘(2) That all annual inventory reports shall
`or State laws that result in or contribute to
`General, shall commence carrying out the na-
`be filed no later than January 15 of the year fol-
`rape, other crimes of violence, or other crimes
`tional campaign under such paragraph in ac-
`lowing that for which the report is submitted
`involving abuse of gamma hydroxybutyric acid,
`cordance with the plan developed under such
`and include data on the stocks of the drug prod-
`other controlled substances, or so-called ‘‘de-
`paragraph. The campaign may be carried out
`uct, drug substance, bulk drug, and dosage
`signer drugs’’; and
`directly by the Secretary and through grants
`(B) model training materials for law enforce-
`forms on hand as of the close of business Decem-
`and contracts.
`(3) EVALUATION BY GENERAL ACCOUNTING OF-
`ment personnel involved in such investigations;
`ber 31, indicating whether materials reported
`FICE.—Not later than two years after the date
`and
`are in storage or in process of manufacturing.
`
`VerDate 27-JAN-2000 02:05 Feb 01, 2000 Jkt 079060 PO 00000 Frm 00006 Fmt 4634 Sfmt 6333 E:\CR\FM\A31JA7.006 pfrm02 PsN: H31PT1
`
`Page 2 of 8
`
`Page 2 of 8
`
`

`

`H57
`January 31, 2000
`CONGRESSIONAL RECORD — HOUSE
`caused him to stop breathing after tak-
`Mr. Speaker, I rise today to ask my
`on which the national campaign under para-
`graph (1) is commenced, the Comptroller General
`ing an over-the-counter herbal supple-
`colleagues to join me in supporting the
`of the United States shall submit to Congress an
`ment containing GBL. Similarly, a 16-
`passage of H.R. 2130, the Hillory J.
`evaluation of the effects with respect to date-
`year-old Peoria, Illinois high school
`Farias and Samantha Reid Date-Rape
`rape drugs of the national campaign.
`student collapsed during a school gym
`Drug Prohibition Act.
`(c) DEFINITION.—For purposes of this section,
`As you may recall, the House ini-
`class after taking a product containing
`the term ‘‘date-rape drugs’’ means gamma hy-
`tially approved this legislation last Oc-
`GBL. He lost consciousness, stopped
`droxybutyric acid and its salts, isomers, and
`tober on a vote of 423 to 1. This evening
`breathing, and had to be resuscitated
`salts of isomers and such other drugs or sub-
`we will vote on this legislation as
`by paramedics.
`stances as the Secretary, after consultation with
`amended by the Senate, and if the leg-
`the Attorney General, determines to be appro-
`The Senate amended H.R. 2130 to fur-
`priate.
`islation is approved, it will go straight
`ther develop and strengthen the De-
`to the President to be signed into law.
`partment of Justice’s focus on GHB
`SEC. 8. SPECIAL UNIT IN DRUG ENFORCEMENT
`The legislation we are considering
`and to provide for the development of
`ADMINISTRATION FOR ASSESSMENT
`today will amend the Controlled Sub-
`forensic field tests for the detection of
`OF ABUSE AND TRAFFICKING OF
`GHB AND OTHER CONTROLLED SUB-
`stances Act to put GHB, a dangerous
`this substance. In all other respects,
`STANCES AND DRUGS.
`(a) ESTABLISHMENT.—Not later than 60 days
`and sometimes fatal drug used to fa-
`the Senate amendments have had the
`after the date of the enactment of this Act, the
`cilitate sexual assaults, in schedule 1 of
`same effect as the legislation that we
`Attorney General shall establish within the Op-
`the Controlled Substances Act, the
`passed here in the House in October.
`erations Division of the Drug Enforcement Ad-
`most tightly regulated category of
`I wish to express my appreciation for
`ministration a special unit which shall assess
`drugs with the strongest penalties for
`the help of so many of my colleagues,
`the abuse of and trafficking in gamma hydroxy-
`misuse.
`the gentleman from Michigan (Mr.
`butyric acid, flunitrazepam, ketamine, other
`It will also clamp tight controls on
`STUPAK), the gentlewoman from Texas
`controlled substances, and other so-called ‘‘de-
`GBL, a precursor to GHB that is itself
`(Ms. JACKSON LEE), the gentleman from
`signer drugs’’ whose use has been associated
`being used to facilitate sexual assaults.
`with sexual assault.
`Florida (Mr. BILIRAKIS), and the gen-
`(b) PARTICULAR DUTIES.—In carrying out the
`This legislation is desperately need-
`tleman from Virginia (Chairman BLI-
`assessment under subsection (a), the special unit
`ed. The abuse, trafficking, and diver-
`LEY), the help that they have given in
`shall—
`sion of GHB is rapidly increasing. The
`getting us to this point, and for the
`(1) examine the threat posed by the substances
`Drug Enforcement Administration has
`leadership of the Senate, particularly
`and drugs referred to in that subsection on a
`documented nearly 6,000 encounters of
`Senator ABRAHAM and Senator HATCH,
`national basis and regional basis; and
`GHB. Deaths from the drug are esca-
`in steering this legislation for Senate
`(2) make recommendations to the Attorney
`lating rapidly, from one in 1990 to 17
`General regarding allocations and reallocations
`approval. This has been a bipartisan ef-
`last year, for a total of 58 deaths.
`of resources in order to address the threat.
`fort from day number one.
`(c) REPORT ON RECOMMENDATIONS.—
`Emergency room episodes resulting
`With all my heart, as the father of a
`(1) REQUIREMENT.—Not later than 180 days
`from the use of the drug are also esca-
`daughter and son, I ask that the House
`after the date of the enactment of this Act, the
`lating rapidly, from 20 in 1992 to 762 in
`approve this legislation tonight and
`Attorney General shall submit to the Committees
`1997, the last year for which data is
`send it to the President. Let us do this
`on the Judiciary of the Senate and House of
`available, for a total of more than 1,600
`for all of our sons and daughters, who
`Representatives a report which shall—
`episodes.
`are at grave risk so long as these sub-
`(A) set forth the recommendations of the spe-
`Sadly, these numbers are reflecting
`cial unit under subsection (b)(2): and
`stances are so readily available.
`(B) specify the allocations and reallocations
`only the tip of an iceberg. GHB is dif-
`Mr. Speaker, I reserve the balance of
`of resources that the Attorney General proposes
`ficult to detect, almost impossible, in
`my time.
`to make in response to the recommendations.
`the body, within a few hours of its
`Ms. JACKSON-LEE of Texas. Mr.
`(2) TREATMENT OF REPORT.—Nothing in para-
`being ingested. Many law enforcement
`Speaker, I yield myself such time as I
`graph (1) may be construed to prohibit the At-
`officers and emergency room personnel
`may consume.
`torney General or the Administrator of the Drug
`are not trained to look for it.
`Mr. Speaker, as a Member of the
`Enforcement Administration from making any
`As an example, I heard from one
`Committee on the Judiciary, the Sub-
`reallocation of existing resources that the Attor-
`source in Kansas City that they sus-
`ney General or the Administrator, as the case
`committee on Crime, I am delighted to
`may be, considers appropriate.
`pected thousands of date rape and drug
`join my colleague, the gentleman from
`abuse cases in the greater Kansas City
`Michigan (Mr. UPTON), a member of the
`SEC. 9. TECHNICAL AMENDMENT.
`Section 401 of the Controlled Substances Act
`region since 1993. The legislation before
`Committee on Commerce, and thank
`(21 U.S.C. 841) is amended by redesignating sub-
`us was sparked by the death of two
`him for his leadership.
`sections (d), (e), (f), and (g) as subsections (c),
`young, wonderful women, one in Texas
`In fact, his leadership was so strong
`(d), (e), and (f), respectively.
`and one in Michigan, whose drinks
`that he was making sure that as I came
`Amend the title so as to read: ‘‘An Act to
`were spiked with GHB. Since then, five
`in and landed at Reagan National, that
`amend the Controlled Substances Act to di-
`more women have died in Texas and
`I would hurry on, and I got here time-
`rect the emergency scheduling of gamma hy-
`another two in Michigan. We must act
`ly. I thank him very much for that.
`droxybutyric acid, to provide for a national
`awareness campaign, and for other pur-
`This has been a very long journey,
`now before this tragic toll rises any
`poses.’’.
`and the one thing that we can applaud,
`further.
`The SPEAKER pro tempore. Pursu-
`The FDA has issued consumer warn-
`Mr. Speaker, is that we have worked
`ant to the rule, the gentleman from
`ings about products containing GBL,
`together, the Committee on Commerce,
`Michigan (Mr. UPTON) and the gentle-
`which converts to GHB, when ingested
`the Committee on the Judiciary, and
`woman from Texas (Ms. JACKSON-LEE)
`in dietary supplements, and has asked
`we have answered the call of so many
`each will control 20 minutes.
`companies marketing products con-
`victims, now I am told almost between
`The Chair recognizes the gentleman
`taining GBL to recall them.
`40 to 50 who have died.
`from Michigan (Mr. UPTON).
`In August of last year the FDA sent
`There was an anecdotal story of a
`a message to help professionals across
`Texas young woman who begged for
`GENERAL LEAVE
`the country, asking them to report ad-
`help, explaining that her whole body
`Mr. UPTON. Mr. Speaker, I ask unan-
`verse events associated with the con-
`hurt so much that the only way to stop
`imous consent that all Members may
`sumption of these products. Since then,
`it is to take more GHB but she wanted
`have 5 legislative days within which to
`the agency has received 122 reports of
`desperately to quit. She had actually
`revise and extend their remarks and in-
`serious adverse reactions, such as dan-
`died two times on GHB and was
`clude extraneous matter on this legis-
`gerously low respiration rates which
`brought back by paramedics. She was
`lation.
`may require intubation, unconscious-
`The SPEAKER pro tempore. Is there
`raped while on GHB. She had not re-
`ness, coma, seizures, irregular heart-
`objection to the request of the gen-
`ported it because she felt it was her
`beat, and yes, death.
`tleman from Michigan?
`fault for getting high.
`Just this last month, as you may
`I am gratified that Members of the
`There was no objection.
`have read, Phoenix Suns player Tom
`Mr. UPTON. Mr. Speaker, I yield my-
`Committee on Commerce, the gentle-
`Gugliotta suffered a seizure that
`self such time as I may consume.
`men from Michigan, Mr. UPTON and Mr.
`
`VerDate 27-JAN-2000 03:04 Feb 01, 2000 Jkt 079060 PO 00000 Frm 00007 Fmt 4634 Sfmt 0634 E:\CR\FM\A31JA7.006 pfrm02 PsN: H31PT1
`
`Page 3 of 8
`
`Page 3 of 8
`
`

`

`H58
`January 31, 2000
`CONGRESSIONAL RECORD — HOUSE
`lapsed into comas during the Fourth of
`who would use this drug and its
`STUPAK, and the gentleman from Vir-
`July holiday last year.
`analogs to commit crimes against
`ginia (Mr. BLILEY) and I introduced
`In addition to the tragic stories of
`women and others. In addition to being
`this bipartisan bill, the Hillory J.
`Hillory and Samantha, my office was
`used for date rape, this drug is being
`Farias Samantha Reid Date Rape Pre-
`contacted by the office of the gen-
`used at alarming rates among young
`vention Act of 1999.
`tleman from New York (Mr. LAFALCE)
`Mr. Speaker, I am also grateful to
`people.
`the ranking member, the gentleman
`with the story of Kerri Breton from
`However, my position does not mean
`from Michigan (Mr. DINGELL), the gen-
`Syracuse, New York, who also died
`I am insensitive to the concerns of pa-
`from this drug being slipped into her
`tleman from Ohio (Mr. BROWN), the
`tients who might be helped by this
`drink. Ms. Breton was away on a busi-
`gentleman from Florida (Mr. BILI-
`drug. This drug has shown some bene-
`ness trip and was having a drink in a
`RAKIS); members of my committee, the
`fits to patients with a specific form of
`hotel bar with a colleague. She was
`gentleman from Florida (Mr. MCCOL-
`narcolepsy in clinical trials, those who
`found next day dead on the bathroom
`LUM), the gentleman from Virginia (Mr.
`suffer from sleeping sickness, and for
`floor of her hotel room. Her stepfather
`SCOTT), the gentleman from Illinois
`those uses during trials to try to cure
`shared this painful story in the hope it
`(Mr. HYDE), and the gentleman from
`that disease.
`would alert others to the dangers of
`Michigan (Mr. CONYERS). This was a bi-
`1430
`this drug.
`partisan effort.
`There is a possibility that GHB can
`Mr. Speaker, this drug is not a re-
`I am looking forward for this bill to
`be used for the treatment of such dis-
`specter of any age. You do not have to
`be supported by my colleagues, and, as
`eases. We want that to occur, because
`be very smart, you do not have to be
`well, to go quickly to the desk of the
`it is a rare disorder. We believe that
`unsmart, if you will; you do not have
`President of the United States.
`this bill matches the medicinal needs
`This is a victory for those of us who
`to be educated or uneducated; you do
`along with the needs to protect our
`are concerned about date rape drugs.
`not have to be rich or poor. This is a
`citizens from the devastation of illegal
`This drug, GHB, has been used in innu-
`drug that respects no one and causes
`use of GHB, known to be made in bath-
`merable rapes around the country and
`the loss of life of wonderful human
`tubs in large amounts.
`has been implicated, as I have said, in
`beings.
`The distribution of this drug would
`A young man from the Chicago area
`at least 40 to 50 deaths. In addition to
`be strictly controlled to ensure that
`overdosed and almost died last Sep-
`date rape, this drug is very popular on
`only patients in need of this drug
`tember. He was using the drug because
`the party scene in many cities, and it
`would have access. This bill also pro-
`he wanted to be a bodybuilder. Just re-
`is widely abused.
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket